Oral formulations of cladribine

Details for Australian Patent Application No. 2004226437 (hide)

Owner Ares Trading S.A.

Inventors Bodor, Nicholas S.; Dandiker, Yogesh

Agent Griffith Hack

Pub. Number AU-B-2004226437

PCT Pub. Number WO2004/087101

Priority 60/484,756 02.07.03 US; 60/458,922 28.03.03 US; 60/541,247 04.02.04 US

Filing date 26 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 3 June 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/52 (2006.01)

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087101 Priority application(s): WO2004/087101

29 March 2007 Assignment before Grant

  Ivax Coporation The application has been assigned to Ares Trading S.A.

3 June 2010 Application Accepted

  Published as AU-B-2004226437

7 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226440-Method and apparatus to prevent medication error in a networked infusion system

2004226435-Cladribine formulations for improved oral and transmucosal delivery